167 related articles for article (PubMed ID: 33302475)
1. RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.
Monroe JD; Moolani SA; Irihamye EN; Speed JS; Gibert Y; Smith ME
Cells; 2020 Dec; 9(12):. PubMed ID: 33302475
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin and phenanthriplatin modulate long-noncoding RNA expression in A549 and IMR90 cells revealing regulation of microRNAs, Wnt/β-catenin and TGF-β signaling.
Monroe JD; Moolani SA; Irihamye EN; Lett KE; Hebert MD; Gibert Y; Smith ME
Sci Rep; 2021 May; 11(1):10408. PubMed ID: 34001990
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
4. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
Park GY; Wilson JJ; Song Y; Lippard SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
[TBL] [Abstract][Full Text] [Related]
5. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
6. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
[TBL] [Abstract][Full Text] [Related]
7. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
[TBL] [Abstract][Full Text] [Related]
8. The monofunctional platinum(II) compounds, phenanthriplatin and pyriplatin, modulate apoptosis signaling pathways in HEI-OC1 auditory hybridoma cells.
Monroe JD; Johnston AM; Smith ME
Neurotoxicology; 2020 Jul; 79():104-109. PubMed ID: 32413439
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
Riddell IA; Johnstone TC; Park GY; Lippard SJ
Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
[TBL] [Abstract][Full Text] [Related]
10. Effects of monofunctional platinum agents on bacterial growth: a retrospective study.
Johnstone TC; Alexander SM; Lin W; Lippard SJ
J Am Chem Soc; 2014 Jan; 136(1):116-8. PubMed ID: 24364388
[TBL] [Abstract][Full Text] [Related]
11. Two new monofunctional platinum(II) dithiocarbamate complexes:
Imran M; Rehman ZU; Hogarth G; Tocher DA; Chaudhry GE; Butler IS; Bélanger-Gariepy F; Kondratyuk T
Dalton Trans; 2020 Nov; 49(43):15385-15396. PubMed ID: 33140800
[TBL] [Abstract][Full Text] [Related]
12. Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes.
Riddell IA; Agama K; Park GY; Pommier Y; Lippard SJ
ACS Chem Biol; 2016 Nov; 11(11):2996-3001. PubMed ID: 27648475
[TBL] [Abstract][Full Text] [Related]
13. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
[TBL] [Abstract][Full Text] [Related]
14. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
[TBL] [Abstract][Full Text] [Related]
15. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
Dabbish E; Russo N; Sicilia E
Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
[TBL] [Abstract][Full Text] [Related]
16. A novel cyclometallated Pt(II)-ferrocene complex induces nuclear FOXO3a localization and apoptosis and synergizes with cisplatin to inhibit lung cancer cell proliferation.
Cortés R; Tarrado-Castellarnau M; Talancón D; López C; Link W; Ruiz D; Centelles JJ; Quirante J; Cascante M
Metallomics; 2014 Mar; 6(3):622-33. PubMed ID: 24492855
[TBL] [Abstract][Full Text] [Related]
17. Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
O'Dowd PD; Guerrero AS; Alley KR; Pigg HC; O'Neill F; Meiller J; Hobbs C; Rodrigues DA; Twamley B; O'Sullivan F; DeRose VJ; Griffith DM
ACS Chem Biol; 2024 Apr; 19(4):875-885. PubMed ID: 38483263
[TBL] [Abstract][Full Text] [Related]
18. Understanding and improving platinum anticancer drugs--phenanthriplatin.
Johnstone TC; Park GY; Lippard SJ
Anticancer Res; 2014 Jan; 34(1):471-6. PubMed ID: 24403503
[TBL] [Abstract][Full Text] [Related]
19. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological approach to the platinum compounds].
Sasaki Y
Gan To Kagaku Ryoho; 1992 Apr; 19(4):456-62. PubMed ID: 1313667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
